REAL-LIFE EFFICACY AND SAFETY OF SUBCUTANEOUS ALLERGEN IMMUNOTHERAPY WITH MOLECULAR ALLERGOID FOR ALTERNARIA ALTERNATA IN ADOLESCENTS AND ADULTS WITH RESPIRATORY ALLERGIES